Sec Form 13G Filing - Knott David M Jr filing for Calumet Specialty Products Partners, L.P. (CLMT) - 2025-02-12

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G



Comment for Type of Reporting Person:  Amounts for Common Units set forth in Rows 5 through 9 and 11 above reflect the following: on July 10, 2024, in connection with the corporate reorganization of the Issuer, pursuant to which the Issuer converted from a master limited partnership to a corporation (the "Conversion"), Calumet Merger Sub I LLC merged with and into Calumet GP, LLC, the general partner (the "General Partner") of the Issuer, with the General Partner continuing as the surviving entity and a wholly owned subsidiary of Calumet, Inc. (the "GP Merger"). In connection with the GP Merger, those Common Units were terminated in full in exchange for common stock of Calumet, Inc.


SCHEDULE 13G



Comment for Type of Reporting Person:  Amounts for Common Units set forth in Rows 5 through 9 and 11 above reflect the following: on July 10, 2024, in connection with the corporate reorganization of the Issuer, pursuant to which the Issuer converted from a master limited partnership to a corporation (the "Conversion"), Calumet Merger Sub I LLC merged with and into Calumet GP, LLC, the general partner (the "General Partner") of the Issuer, with the General Partner continuing as the surviving entity and a wholly owned subsidiary of Calumet, Inc. (the "GP Merger"). In connection with the GP Merger, those Common Units were terminated in full in exchange for common stock of Calumet, Inc.


SCHEDULE 13G



Comment for Type of Reporting Person:  Amounts for Common Units set forth in Rows 5 through 9 and 11 above reflect the following: on July 10, 2024, in connection with the corporate reorganization of the Issuer, pursuant to which the Issuer converted from a master limited partnership to a corporation (the "Conversion"), Calumet Merger Sub I LLC merged with and into Calumet GP, LLC, the general partner (the "General Partner") of the Issuer, with the General Partner continuing as the surviving entity and a wholly owned subsidiary of Calumet, Inc. (the "GP Merger"). In connection with the GP Merger, those Common Units were terminated in full in exchange for common stock of Calumet, Inc.


SCHEDULE 13G


 
Knott David M Jr
 
Signature:/s/ David M. Knott, Jr.
Name/Title:David M. Knott, Jr.
Date:02/12/2025
 
Dorset Partners LLC
 
Signature:/s/ David M. Knott, Jr.
Name/Title:David M. Knott, Jr./ Executive Managing Member
Date:02/12/2025
 
KNOTT PARTNERS LP
 
Signature:/s/ David M. Knott, Jr.
Name/Title:By: Knott Partners Management, LLC, as general partner, David M. Knott, Jr./ Executive Managing Member
Date:02/12/2025
primary_doc.xml